Source: KAORI YOSHIDA, Nikkei Asia staff writer
“NEW YORK — Prices of laboratory monkeys in the U.S. have jumped around 15-fold from pre-COVID levels, with China having blocked exports and a new stable source yet to be found.
The shortage could delay development by American pharmaceutical manufacturers, making the problem a matter of national economic security.
Prices of species commonly used in lab testing, such as long-tailed macaques and rhesus monkeys, rose to around $55,000 to $60,000 in April, according to Evercore ISI analyst Elizabeth Anderson. January’s range of about $35,000 to $40,000 was already up sharply from the pre-virus level of around $4,000 to $7,000…”
